Future of Mechanical Circulatory Support Devices in Children and Young Adults

David L. Sutcliffe, Robert D.B. Jacquiss

Research output: Chapter in Book/Report/Conference proceedingChapter


Mechanical circulatory support has revolutionized heart failure management for adult and pediatric patients alike. Though the field has been marked by near continuous technologic advances, its origins are undoubtedly inauspicious. First performed in 1966, Dr. Michael Debakey described the use of an extracorporeal, pulsatile device to support the circulation of a 37-year-old woman for a mere 10. days (DeBakey, 1971). However, it was not until the early 1990s that the use of ventricular assist device (VAD) technology became routine with the FDA approval of the HeartMate IP left ventricular assist system (Fig. 55.1A). This and other similar first generation VADs utilized pneumatically driven, pulsatile pumps to offload the failing ventricle and provide adequate blood flow to reverse the unrelenting course of end-stage heart failure.

Original languageEnglish (US)
Title of host publicationHeart Failure in the Child and Young Adult
Subtitle of host publicationFrom Bench to Bedside
Number of pages8
ISBN (Electronic)9780128026137
ISBN (Print)9780128023938
StatePublished - Jan 1 2018


  • End-stage heart failure
  • FDA approval
  • Heart failure management
  • HeartMate IP LVAS
  • Pediatric heart failure
  • VAD
  • Ventricular assist device

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Future of Mechanical Circulatory Support Devices in Children and Young Adults'. Together they form a unique fingerprint.

Cite this